Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2zb3 | NDP | Prostaglandin reductase 2 | 1.3.1.48 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2zb3 | NDP | Prostaglandin reductase 2 | 1.3.1.48 | 1.000 | |
| 2vna | NAP | Prostaglandin reductase 2 | 1.3.1.48 | 0.576 | |
| 2c0c | NAP | Prostaglandin reductase 3 | 1 | 0.473 | |
| 2y05 | NAP | Prostaglandin reductase 1 | / | 0.461 | |
| 4b7x | NAP | Probable oxidoreductase | / | 0.461 | |
| 4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.457 | |
| 2j3i | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.447 | |
| 2j3k | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.442 |